Prescription drug · ANDA
Betamethasone dipropionate NDC 16714-996
Betamethasone dipropionate .5 mg/g · Cream · Topical · Northstar Rx LLC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 16714-996-01 | 16714099601 | 1 TUBE in 1 CARTON (16714-996-01) / 15 g in 1 TUBEMarketed from Oct 10, 2019 | |
| 16714-996-02 | 16714099602 | 1 TUBE in 1 CARTON (16714-996-02) / 45 g in 1 TUBEMarketed from Oct 10, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Betamethasone dipropionate
- Generic name (nonproprietary)
- betamethasone dipropionate
- Active ingredients
- Betamethasone dipropionate — .5 mg/g
- Dosage form
- Cream
- Route
- Topical
- Labeler
- Northstar Rx LLC.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208885
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 16714-996_66c8f094-ba44-41e8-8917-3800f05152fcSPL ID 66c8f094-ba44-41e8-8917-3800f05152fcSPL set ID 395d40c0-22d9-48d1-8d8e-eeaddf33c53eRxCUI 238920UNII 826Y60901UUPC 0316714996011
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N416714099601followed by a unit qualifier and the quantityPackage 16714-0996-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 208885
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Betamethasone dipropionate | Betamethasone dipropionate .5 mg/g | CreamTopical | A-S Medication Solutions | 50090-4680 |
| Betamethasone dipropionate | Betamethasone dipropionate .5 mg/g | CreamTopical | Zydus Pharmaceuticals USA Inc. | 70710-1233 |
| Betamethasone dipropionate | Betamethasone dipropionate .5 mg/g | CreamTopical | Zydus Lifesciences Limited | 70771-1380 |
| Betamethasone dipropionate | Betamethasone dipropionate .5 mg/g | CreamTopical | Redpharm Drug | 67296-2275 |
| Betamethasone dipropionate | Betamethasone dipropionate .5 mg/g | CreamTopical | A-S Medication Solutions | 50090-7525 |